The JI Acurri Cytometers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carrasco-Marin, E.
Right arrow Articles by Unanue, E. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carrasco-Marin, E.
Right arrow Articles by Unanue, E. R.

The Journal of Immunology, Vol 156, Issue 2 450-458, Copyright © 1996 by American Association of Immunologists

ARTICLES

The class II MHC I-Ag7 molecules from non-obese diabetic mice are poor peptide binders

E Carrasco-Marin, J Shimizu, O Kanagawa and ER Unanue
Center for Immunology, Washington University School of Medicine, St. Louis, MO 63110, USA.

The class II molecules of the diabetes-prone NOD mice, I-Ag7, showed very limited amounts of stable form when analyzed by SDS-PAGE. We included the analysis of spleen B cells and B lymphoma cells transfected with I-Ag7 genes. Early during bio-synthesis there was invariant chain binding to the alpha beta-chains. Examination of APCs from F1 mice (NOD x C57BL/6) indicated that the same APC expressed high levels of unstable I-Ag7 and normal amounts of stable class II molecules compared with the other haplotype (I-Ab). The half-life of I- Ag7-peptide complexes on the cell surface of APC was significantly shorter than that of other class II haplotypes. Direct biochemical demonstration of peptide interactions with I-Ag7 was difficult to demonstrate. In T cell assays, the immunogenic peptides, including the diabetogenic Ag, were rapidly lost when peptide-pulsed APCs were washed free of peptide. We hypothesize that the weak and unstable peptide- binding property of I-Ag7 molecules does not favor the elimination or inactivation of autoreactive T cells.


This article has been cited by other articles:


Home page
 DiabetesHome page
L. Li, B. Wang, J. A. Frelinger, and R. Tisch
T-Cell Promiscuity in Autoimmune Diabetes
Diabetes, August 1, 2008; 57(8): 2099 - 2106.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. A. James and W. W. Kwok
Low-Affinity Major Histocompatibility Complex-Binding Peptides in Type 1 Diabetes
Diabetes, July 1, 2008; 57(7): 1788 - 1789.
[Full Text] [PDF]

Home page
 DiabetesHome page
M. G. Levisetti, D. M. Lewis, A. Suri, and E. R. Unanue
Weak Proinsulin Peptide-Major Histocompatibility Complexes Are Targeted in Autoimmune Diabetes in Mice
Diabetes, July 1, 2008; 57(7): 1852 - 1860.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
T. Yoshida, F. Jiang, T. Honjo, and T. Okazaki
PD-1 deficiency reveals various tissue-specific autoimmunity by H-2b and dose-dependent requirement of H-2g7 for diabetes in NOD mice
PNAS, March 4, 2008; 105(9): 3533 - 3538.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. G. Levisetti, A. Suri, S. J. Petzold, and E. R. Unanue
The Insulin-Specific T Cells of Nonobese Diabetic Mice Recognize a Weak MHC-Binding Segment in More Than One Form
J. Immunol., May 15, 2007; 178(10): 6051 - 6057.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. J. Mellanby, C. H. Koonce, A. Monti, J. M. Phillips, A. Cooke, and E. K. Bikoff
Loss of Invariant Chain Protects Nonobese Diabetic Mice against Type 1 Diabetes
J. Immunol., December 1, 2006; 177(11): 7588 - 7598.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Inaba, W. Martin, A. S. De Groot, S. Qin, and L. J. De Groot
Thyrotropin Receptor Epitopes and Their Relation to Histocompatibility Leukocyte Antigen-DR Molecules in Graves' Disease
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2286 - 2294.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
W. Jiang, M. S. Anderson, R. Bronson, D. Mathis, and C. Benoist
Modifier loci condition autoimmunity provoked by Aire deficiency
J. Exp. Med., September 19, 2005; 202(6): 805 - 815.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
N. N. Logunova, C. Viret, L. A. Pobezinsky, S. A. Miller, D. B. Kazansky, J. P. Sundberg, and A. V. Chervonsky
Restricted MHC-peptide repertoire predisposes to autoimmunity
J. Exp. Med., July 5, 2005; 202(1): 73 - 84.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
C. H. Koonce and E. K. Bikoff
Dissecting MHC Class II Export, B Cell Maturation, and DM Stability Defects in Invariant Chain Mutant Mice
J. Immunol., September 1, 2004; 173(5): 3271 - 3280.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
A. C. Anderson and V. K. Kuchroo
Expression of Self-antigen in the Thymus: A Little Goes a Long Way
J. Exp. Med., December 1, 2003; 198(11): 1627 - 1629.
[Full Text] [PDF]

Home page
 J. Immunol.Home page
J. C. Huang, M. Han, A. Minguela, S. Pastor, A. Qadri, and E. S. Ward
T Cell Recognition of Distinct Peptide:I-Au Conformers in Murine Experimental Autoimmune Encephalomyelitis
J. Immunol., September 1, 2003; 171(5): 2467 - 2477.
[Abstract] [Full Text] [PDF]

Home page
 Protein Eng Des SelHome page
S. E. Starwalt, E. L. Masteller, J. A. Bluestone, and D. M. Kranz
Directed evolution of a single-chain class II MHC product by yeast display
Protein Eng. Des. Sel., February 1, 2003; 16(2): 147 - 156.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Reddy, E. Bettelli, L. Nicholson, H. Waldner, M.-H. Jang, K. W. Wucherpfennig, and V. K. Kuchroo
Detection of Autoreactive Myelin Proteolipid Protein 139-151-Specific T Cells by Using MHC II (IAs) Tetramers
J. Immunol., January 15, 2003; 170(2): 870 - 877.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Koarada, Y. Wu, G. Olshansky, and W. M. Ridgway
Increased Nonobese Diabetic Th1:Th2 (IFN-{gamma}:IL-4) Ratio Is CD4+ T Cell Intrinsic and Independent of APC Genetic Background
J. Immunol., December 1, 2002; 169(11): 6580 - 6587.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
F. Gentile, P. Amodeo, F. Febbraio, F. Picaro, A. Motta, S. Formisano, and R. Nucci
SDS-resistant Active and Thermostable Dimers Are Obtained from the Dissociation of Homotetrameric beta -Glycosidase from Hyperthermophilic Sulfolobus solfataricus in SDS. STABILIZING ROLE OF THE A-C INTERMONOMERIC INTERFACE
J. Biol. Chem., November 8, 2002; 277(46): 44050 - 44060.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Suri, I. Vidavsky, K. van der Drift, O. Kanagawa, M. L. Gross, and E. R. Unanue
In APCs, the Autologous Peptides Selected by the Diabetogenic I-Ag7 Molecule Are Unique and Determined by the Amino Acid Changes in the P9 Pocket
J. Immunol., February 1, 2002; 168(3): 1235 - 1243.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
A. Quinn, M. Melo, D. Ethell, and Eli. E. Sercarz
Relative resistance to nasally induced tolerance in non-obese diabetic mice but not other I-Ag7-expressing mouse strains
Int. Immunol., October 1, 2001; 13(10): 1321 - 1333.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Bot, D. Smith, S. Bot, A. Hughes, T. Wolfe, L. Wang, C. Woods, and M. v. Herrath
Plasmid Vaccination with Insulin B Chain Prevents Autoimmune Diabetes in Nonobese Diabetic Mice
J. Immunol., September 1, 2001; 167(5): 2950 - 2955.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Koarada, Y. Wu, and W. M. Ridgway
Increased Entry into the IFN-{gamma} Effector Pathway by CD4+ T Cells Selected by I-Ag7 on a Nonobese Diabetic Versus C57BL/6 Genetic Background
J. Immunol., August 1, 2001; 167(3): 1693 - 1702.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Bhatnagar, P. J. Milburn, M. Lobigs, R. V. Blanden, and A. M. Gautam
Nonobese Diabetic Mice Display Elevated Levels of Class II-Associated Invariant Chain Peptide Associated with I-Ag7 on the Cell Surface
J. Immunol., April 1, 2001; 166(7): 4490 - 4497.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Basu, S. Horvath, L. O'Mara, D. Donermeyer, and P. M. Allen
Two MHC Surface Amino Acid Differences Distinguish Foreign Peptide Recognition from Autoantigen Specificity
J. Immunol., March 15, 2001; 166(6): 4005 - 4011.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
D. J Kilmartin, D. Wilson, J. Liversidge, A. D Dick, J. Bruce, R. W Acheson, S. J Urbaniak, and J. V Forrester
Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients
Br. J. Ophthalmol., March 1, 2001; 85(3): 281 - 286.
[Abstract] [Full Text]

Home page
 J. Immunol.Home page
D. V. Serreze, H. D. Chapman, C. M. Post, E. A. Johnson, W. L. Suarez-Pinzon, and A. Rabinovitch
Th1 to Th2 Cytokine Shifts in Nonobese Diabetic Mice: Sometimes an Outcome, Rather Than the Cause, of Diabetes Resistance Elicited by Immunostimulation
J. Immunol., January 15, 2001; 166(2): 1352 - 1359.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C.-P. Liu, K. Jiang, C.-H. Wu, W.-H. Lee, and W.-J. Lin
Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers
PNAS, November 29, 2000; (2000) 250390997.
[Abstract] [Full Text]

Home page
 Int ImmunolHome page
C. G. Radu, S. M. Anderton, M. Firan, D. C. Wraith, and E. S. Ward
Detection of autoreactive T cells in H-2u mice using peptide-MHC multimers
Int. Immunol., November 1, 2000; 12(11): 1553 - 1560.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. Winer, L. Gunaratnam, I. Astsatourov, R. K. Cheung, V. Kubiak, W. Karges, D. Hammond-McKibben, R. Gaedigk, D. Graziano, M. Trucco, et al.
Peptide Dose, MHC Affinity, and Target Self-Antigen Expression Are Critical for Effective Immunotherapy of Nonobese Diabetic Mouse Prediabetes
J. Immunol., October 1, 2000; 165(7): 4086 - 4094.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. Stratmann, V. Apostolopoulos, V. Mallet-Designe, A. L. Corper, C. A. Scott, I. A. Wilson, A. S. Kang, and L. Teyton
The I-Ag7 MHC Class II Molecule Linked to Murine Diabetes Is a Promiscuous Peptide Binder
J. Immunol., September 15, 2000; 165(6): 3214 - 3225.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. A. Ettinger, A. W. Liu, G. T. Nepom, and W. W. Kwok
{beta}57-Asp Plays an Essential Role in the Unique SDS Stability of HLA-DQA1*0102/DQB1*0602 {alpha}{beta} Protein Dimer, the Class II MHC Allele Associated with Protection from Insulin-Dependent Diabetes Mellitus
J. Immunol., September 15, 2000; 165(6): 3232 - 3238.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
L. S. Arneson, M. Peterson, and A. J. Sant
The MHC Class II Molecule I-Ag7 Exists in Alternate Conformations That Are Peptide Dependent
J. Immunol., August 15, 2000; 165(4): 2059 - 2067.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Basu, S. Horvath, I. Matsumoto, D. H. Fremont, and P. M. Allen
Molecular Basis for Recognition of an Arthritic Peptide and a Foreign Epitope on Distinct MHC Molecules by a Single TCR
J. Immunol., June 1, 2000; 164(11): 5788 - 5796.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
O. Kanagawa, J. Shimizu, and B. A. Vaupel
Thymic and Postthymic Regulation of Diabetogenic CD8 T Cell Development in TCR Transgenic Nonobese Diabetic (NOD) Mice
J. Immunol., May 15, 2000; 164(10): 5466 - 5473.
[Abstract] [Full Text] [PDF]

Home page
 ScienceHome page
A. L. Corper, T. Stratmann, V. Apostolopoulos, C. A. Scott, K. C. Garcia, A. S. Kang, I. A. Wilson, and L. Teyton
A Structural Framework for Deciphering the Link Between I-Ag7 and Autoimmune Diabetes
Science, April 21, 2000; 288(5465): 505 - 511.
[Abstract] [Full Text]

Home page
 Int ImmunolHome page
S. Gregori, E. Bono, F. Gallazzi, J. Hammer, L. C. Harrison, and L. Adorini
The motif for peptide binding to the insulin-dependent diabetes mellitus-associated class II MHC molecule I-Ag7 validated by phage display library
Int. Immunol., April 1, 2000; 12(4): 493 - 503.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. Sawai and L. J. DeGroot
Binding of Human Thyrotropin Receptor Peptides to a Graves' Disease-Predisposing Human Leukocyte Antigen Class II Molecule
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1176 - 1179.
[Abstract] [Full Text]

Home page
 J. Exp. Med.Home page
L. Wen, F. S. Wong, J. Tang, N.-Y. Chen, M. Altieri, C. David, R. Flavell, and R. Sherwin
In Vivo Evidence for the Contribution of Human Histocompatibility Leukocyte Antigen (HLA)-DQ Molecules to the Development of Diabetes
J. Exp. Med., January 3, 2000; 191(1): 97 - 104.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
E. Carrasco-Marin, S. Petzold, and E. R. Unanue
Two Structural States of Complexes of Peptide and Class II Major Histocompatibility Complex Revealed by Photoaffinity-labeled Peptides
J. Biol. Chem., October 29, 1999; 274(44): 31333 - 31340.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
D. H.F. Hausmann, B. Yu, S. Hausmann, and K. W. Wucherpfennig
pH-dependent Peptide Binding Properties of the Type I Diabetes-associated I-Ag7 Molecule: Rapid Release of CLIP at an Endosomal pH
J. Exp. Med., June 7, 1999; 189(11): 1723 - 1734.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. Verdaguer2, A. Amrani2, B. Anderson, D. Schmidt, and P. Santamaria
Two Mechanisms for the Non-MHC-Linked Resistance to Spontaneous Autoimmunity
J. Immunol., April 15, 1999; 162(8): 4614 - 4626.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
D. Schmidt, A. Amrani, J. Verdaguer, S. Bou, and P. Santamaria
Autoantigen-Independent Deletion of Diabetogenic CD4+ Thymocytes by Protective MHC Class II Molecules
J. Immunol., April 15, 1999; 162(8): 4627 - 4636.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
E. R. Unanue
Chemical Features of Peptide Selection by the Class II Histocompatibility Molecules
Am. J. Pathol., March 1, 1999; 154(3): 651 - 664.
[Full Text] [PDF]

Home page
 J. Exp. Med.Home page
W. M. Ridgway, H. Ito, M. Fasso, C. Yu, and C. Garrison Fathman
Analysis of the Role of  Variation of Major Histocompatibility Complex Class II Expression on Nonobese Diabetic (NOD) Peripheral T Cell Response
J. Exp. Med., December 21, 1998; 188(12): 2267 - 2275.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
R. A. Ettinger, A. W. Liu, G. T. Nepom, and W. W. Kwok
Exceptional Stability of the HLA-DQA1*0102/DQB1*0602 {alpha}{beta} Protein Dimer, the Class II MHC Molecule Associated with Protection from Insulin-Dependent Diabetes Mellitus
J. Immunol., December 1, 1998; 161(11): 6439 - 6445.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
O. Kanagawa, B. A. Vaupel, G. Xu, E. R. Unanue, and J. D. Katz
Cutting Edge: Thymic Positive Selection and Peripheral Activation of Islet Antigen-Specific T Cells: Separation of Two Diabetogenic Steps by an I-Ag7 Class II MHC {beta}-Chain Mutant
J. Immunol., November 1, 1998; 161(9): 4489 - 4492.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
M. Peterson and A. J. Sant
The Inability of the Nonobese Diabetic Class II Molecule to Form Stable Peptide Complexes Does Not Reflect a Failure to Interact Productively with DM
J. Immunol., September 15, 1998; 161(6): 2961 - 2967.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. V. Chervonsky, R. M. Medzhitov, L. K. Denzin, A. K. Barlow, A. Yu. Rudensky, and C. A. Janeway Jr.
Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides
PNAS, August 18, 1998; 95(17): 10094 - 10099.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
O. Kanagawa, S. M. Martin, B. A. Vaupel, E. Carrasco-Marin, and E. R. Unanue
Autoreactivity of T cells from nonobese diabetic mice: An I-Ag7-dependent reaction
PNAS, February 17, 1998; 95(4): 1721 - 1724.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
F. Luhder, J. Katz, C. Benoist, and D. Mathis
Major Histocompatibility Complex Class II Molecules Can Protect from Diabetes by Positively Selecting T Cells with Additional Specificities
J. Exp. Med., February 2, 1998; 187(3): 379 - 387.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
L. S. Wicker
Major Histocompatibility Complex-linked Control of Autoimmunity
J. Exp. Med., October 6, 1997; 186(7): 973 - 975.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
J. D. Rabinowitz, M. N. Liang, K. Tate, C. Lee, C. Beeson, and H. M. McConnell
Specific T cell recognition of kinetic isomers in the binding of peptide to class II major histocompatibility complex
PNAS, August 5, 1997; 94(16): 8702 - 8707.
[Abstract] [Full Text] [PDF]

Home page
 J. Exp. Med.Home page
L. C. Harrison, M. C. Honeyman, S. Trembleau, S. Gregori, F. Gallazzi, P. Augstein, V. Brusic, J. Hammer, and L. Adorini
A Peptide-binding Motif for I-Ag7, the Class II Major Histocompatibility Complex (MHC) Molecule of NOD and Biozzi AB/H Mice
J. Exp. Med., March 17, 1997; 185(6): 1013 - 1022.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
C.-P. Liu, K. Jiang, C.-H. Wu, W.-H. Lee, and W.-J. Lin
Detection of glutamic acid decarboxylase-activated T cells with I-Ag7 tetramers
PNAS, December 19, 2000; 97(26): 14596 - 14601.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1996 by The American Association of Immunologists, Inc. All rights reserved.